一种稳定的脂质诱导的α-synuclein聚合物
Malte Drescher1, Bart D van Rooijen, Gertjan Veldhuis
1Department of Molecular Physics, Leiden University, P.O. Box 9504, 2300 RA Leiden, The Netherlands.
Journal of the American Chemical Society
|March 5, 2010
概括
帕金森病的蛋白质alpha-Synuclein (alphaS) 与囊泡一起形成脂质诱导的聚合物. 这些聚合物解释了蛋白质的马结构,并导致膜泄漏,可能解决文献上的差异.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 神经科学是一个神经科学.
背景情况:
- 阿尔法-同核素 (alphaS) 本质上是有障碍的,并且与帕金森病有关.
- 它与膜的相互作用对其功能和病理学至关重要.
- 了解alphaS聚合是解读它在神经退行中的作用的关键.
研究的目的:
- 研究alpha-Synuclein (alphaS) 在与脂质囊泡相互作用时的聚合机制.
- 阐明alphaS聚合的结构基础及其对膜完整性的影响.
主要方法:
- 电子偏磁共振 (EPR) 频谱学.使用Spin标签.
- 双电子共振 (DEER) 用于测量分子间距离.
- 利用alphaS的四个单个突变来探测聚合物形成.
主要成果:
- 阿尔法-同核素 (alphaS) 与POPG SUV形成了明确的聚合物.
- 两种不同的二元结构共存,在螺旋2 (残留50-100) 中发生主要相互作用.
- 聚合物形成解释了先前观察到的马形状,并诱导了膜泄漏和尺寸缩小.
结论:
- 脂质诱导的alphaS聚合为马形状提供了结构上的理由.
- 观察到的膜破坏可能解释了先前研究中的相互矛盾的发现.
- 这项研究提供了有关帕金森病的alphaS病理生物学的见解.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


